Phase I Trials Products (Haemophilia)
Q4, 2021
Trials Products Approved (Obesity)
Q3, 2022
Phase III Trials Products (Obesity)
Q3, 2022
Metrics | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q4, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q4, 2021 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Phase I Trials Products (Haemophilia) | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||
Trials Products Approved (Obesity) | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Phase III Trials Products (Obesity) | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||
Phase II Trials Products (Obesity) | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 |
Phase I Trials Products (Obesity) | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 1 |
Trials Products Approved (Diabetes) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Phase III Trials Products (Diabetes) | 2 | 2 | 4 | 6 | 2 | 2 | 2 | 3 | 3 | 3 |
Phase II Trials Products (Diabetes) | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 2 | ||
Phase I Trials Products (Diabetes) | 4 | 4 | 5 | 7 | 7 | 7 | 7 | 4 | 4 | 6 |
Phase III Trials Products (Other Serious Chronic Diseases) | 2 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | ||
Phase II Trials Products (Other Serious Chronic Diseases) | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 5 | 4 |
Phase I Trials Products (Other Serious Chronic Diseases) | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 3 | 1 | 1 |
Trials Products Approved (Growth Disorders) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||
Trials Products Submitted (Growth Disorders) | 1 | 1 | 1 | 1 | 2 | |||||
Phase III Trials Products (Growth Disorders) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | |
Phase II Trials Products (Growth Disorders) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||
Trials Products Approved (Haemophilia) | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 |
Phase III Trials Products (Haemophilia) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 |
Phase II Trials Products (Haemophilia) | 1 | 1 | 1 | 1 | 1 | 2 | ||||
Trials Products Submitted (Obesity) | 1 | 1 | 1 | 1 | ||||||
Trials Products Submitted (Diabetes) | 1 | 1 | 1 | 1 | 1 | |||||
Trials Products Submitted (Haemophilia) | 2 |
Community
Employees
Environment
Governance
Source:CSRHub
Ads
Analytics
CDN
Cdn
Cdns
Cms
Copyright
Css
Feeds
Framework
Hosting
Javascript